Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or OlderThe New England journal of medicine, 2016-09, Vol.375 (11), p.1019-1032 [Peer Reviewed Journal]Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1603800 ;PMID: 27626517Full text available |
|
2 |
Material Type: Article
|
Efficacy of an Adjuvanted Herpes Zoster Subunit Vaccine in Older AdultsThe New England journal of medicine, 2015-05, Vol.372 (22), p.2087-2096 [Peer Reviewed Journal]Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1501184 ;PMID: 25916341Full text available |
|
3 |
Material Type: Article
|
Structure-based programming of lymph-node targeting in molecular vaccinesNature (London), 2014-03, Vol.507 (7493), p.519-522 [Peer Reviewed Journal]COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Mar 27, 2014 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature12978 ;PMID: 24531764 ;CODEN: NATUASFull text available |
|
4 |
Material Type: Article
|
Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trialThe Lancet (British edition), 2021-02, Vol.397 (10275), p.682-694 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00241-5 ;PMID: 33524311Full text available |
|
5 |
Material Type: Article
|
A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunityNature (London), 2022-01, Vol.601 (7894), p.617-622 [Peer Reviewed Journal]2022. The Author(s). ;Copyright Nature Publishing Group Jan 27, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04232-5 ;PMID: 34814158Full text available |
|
6 |
Material Type: Article
|
Vaccine protection against Zika virus from BrazilNature (London), 2016-08, Vol.536 (7617), p.474-478 [Peer Reviewed Journal]COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Aug 25, 2016 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature18952 ;PMID: 27355570 ;CODEN: NATUASFull text available |
|
7 |
Material Type: Article
|
Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer VaccinesThe New England journal of medicine, 2023-03, Vol.388 (12), p.1142-1145 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2216233 ;PMID: 36856580Full text available |
|
8 |
Material Type: Article
|
An invariant Trypanosoma vivax vaccine antigen induces protective immunityNature (London), 2021-07, Vol.595 (7865), p.96-100 [Peer Reviewed Journal]Copyright Nature Publishing Group Jul 1, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03597-x ;PMID: 34040257Full text available |
|
9 |
Material Type: Article
|
How protein-based COVID vaccines could change the pandemicNature (London), 2021-11, Vol.599 (7885), p.359-360 [Peer Reviewed Journal]Copyright Nature Publishing Group Nov 18, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03025-0 ;PMID: 34750543Full text available |
|
10 |
Material Type: Article
|
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityNature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199Full text available |
|
11 |
Material Type: Article
|
Immunotherapy offers a promising bet against brain cancerNature (London), 2018-09, Vol.561 (7724), p.S42-S44 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-018-06705-6 ;PMID: 30258155Full text available |
|
12 |
Material Type: Article
|
The race for coronavirus vaccines: a graphical guideNature (London), 2020-04, Vol.580 (7805), p.576-577 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-020-01221-y ;PMID: 32346146Full text available |
|
13 |
Material Type: Article
|
Building a better lymphoma vaccineNature (London), 2018-11, Vol.563 (7731), p.S52-S54 [Peer Reviewed Journal]ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-018-07366-1 ;PMID: 30429570Full text available |
|
14 |
Material Type: Article
|
Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trialThe Lancet (British edition), 2003-12, Vol.362 (9400), p.1959-1966 [Peer Reviewed Journal]2003 Elsevier Ltd ;2004 INIST-CNRS ;Copyright Lancet Ltd. Dec 13, 2003 ;Copyright Elsevier Limited Dec 13, 2003 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(03)15014-3 ;PMID: 14683655 ;CODEN: LANCAOFull text available |
|
15 |
Material Type: Article
|
Save the childrenNature, 2004-08, Vol.430 (7002), p.940-941 [Peer Reviewed Journal]COPYRIGHT 2004 Nature Publishing Group ;Copyright Macmillan Journals Ltd. Aug 19, 2004 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/430940a ;PMID: 15318239 ;CODEN: NATUASFull text available |